FI126109B - Nanofibrillipolysakkaridi käytettäväksi kuroutumisen ja arpeutumisen hallitsemiseen ja estoon - Google Patents
Nanofibrillipolysakkaridi käytettäväksi kuroutumisen ja arpeutumisen hallitsemiseen ja estoon Download PDFInfo
- Publication number
- FI126109B FI126109B FI20135172A FI20135172A FI126109B FI 126109 B FI126109 B FI 126109B FI 20135172 A FI20135172 A FI 20135172A FI 20135172 A FI20135172 A FI 20135172A FI 126109 B FI126109 B FI 126109B
- Authority
- FI
- Finland
- Prior art keywords
- hydrogel
- nanofibrillary
- polysaccharide
- nfc
- wound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/009—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Claims (13)
1. Nanofibrilli polysakkaridi hydrogeeli käytettäväksi arpien muodostumisen ja kuroutumisen ehkäisyyn ja hallintaan haavan paranemisen tai kudoksen korjaamisen yhteydessä, missä mainittu nanofibrilli polysakkaridi hydrogeeli käsittää selluloosien ja niiden yhdistelmien joukosta valittua polysakkaridia ja missä mainittu selluloosa on kasviperäinen.
2. Patenttivaatimuksen 1 mukainen nanofibrilli polysakkaridi hydrogeeli, missä mainittu nanofibrilli polysakkaridi hydrogeeli käsittää selluloosien, hemiselluloosien, kitiinien, kitosaanien, alginaattien, pektiinien, arabinksylaanien ja niiden yhdistelmien joukosta valittua polysakkaridia.
3. Patenttivaatimuksen 1 tai 2 mukainen nanofibrilli polysakkaridi hydrogeeli, missä mainittu nanofibrilli polysakkaridi hydrogeeli käsittää polysakkaridinanofibrillejä ja/tai nanofibrillinippuja, joiden numerokeskimääräinen halkaisija on välillä 1 ja 500 nm, edullisesti välillä 2 ja 200 nm.
4. Jonkin patenttivaatimuksen 1-3 mukainen nanofibrilli polysakkaridi hydrogeeli, missä mainitun nanofibrilli polysakkaridi hydrogeelin varastomoduuli on välillä 1-50 Pa, edullisesti välillä 3-20 Pa, vedessä 0,5 p-% pitoisuudessa.
5. Jonkin patenttivaatimuksen 1-4 mukainen nanofibrilli polysakkaridi hydrogeeli, missä mainitun nanofibrilli polysakkaridi hydrogeelin myötöraja on välillä 0.1 - 50 Pa, edullisesti välillä 2-15 Pa, vedessä 0,5 p-% pitoisuudessa.
6. Jonkin patenttivaatimuksen 1-5 mukainen nanofibrilli polysakkaridi hydrogeeli, missä mainitun nanofibrilli polysakkaridi hydrogeelin nolla-leikkausviskositeetti on välillä 100 - 100 000 Pas, edullisesti välillä 5000 -50 000 Pas, vedessä 0,5 p-% pitoisuudessa.
7. Jonkin patenttivaatimuksen 1-6 mukainen nanofibrilli polysakkaridi hydrogeeli, missä mainittu nanofibrilli polysakkaridi on natiivi nanofibrilli selluloosa tai anioninen nanofibrilli selluloosa.
8. Jonkin patenttivaatimuksen 1-7 mukainen nanofibrilli polysakkaridi hydrogeeli, missä mainittu hydrogeeli sisältää 0.01 - 30 p-%, edullisesti 0.05 -5 wt% nanofibrilli polysakkaridia tai niiden yhdistelmää.
9. Jonkin patenttivaatimuksen 1-8 mukainen nanofibrilli polysakkaridi hydrogeeli, missä mainittu hydrogeeli käsittää yhtä tai useampaa bioaktiivisten aineiden, solujen ja ravintolisäaineiden joukosta valittua ainetta.
10. Jonkin patenttivaatimuksen 1-9 mukainen nanofibrilli polysakkaridi hydrogeeli, missä mainittuun hydrogeeliin on kiinnitetty alusta tai se on sisällytetty kantajalle.
11. Jonkin patenttivaatimuksen 1-10 mukainen nanofibrilli polysakkaridi hydrogeeli käytettäväksi kuroutumisen ehkäisyyn ja hallintaan haavan paranemisen tai kudoksen korjaamisen yhteydessä.
12. Jonkin patenttivaatimuksen 1 - 11 mukaista nanofibrilli polysakkaridi hydrogeeliä käsittävä annostelulaite.
13. Patenttivaatimuksen 12 mukainen annostelulaite, missä mainittu annostelulaite on sisällytetty kittiin.
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20135172A FI126109B (fi) | 2013-02-22 | 2013-02-22 | Nanofibrillipolysakkaridi käytettäväksi kuroutumisen ja arpeutumisen hallitsemiseen ja estoon |
| CA2897514A CA2897514C (en) | 2013-02-22 | 2014-02-21 | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
| US14/767,857 US9833540B2 (en) | 2013-02-22 | 2014-02-21 | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
| ES14708926.2T ES2614908T3 (es) | 2013-02-22 | 2014-02-21 | Polisacárido nanofibrilar para su utilización en el control y la prevención de la contracción y la formación de cicatrices |
| DK14708926.2T DK2958599T3 (en) | 2013-02-22 | 2014-02-21 | NANOFIBRILLARY POLYSACCHARIDE USED BY CONTROL AND PREVENTION OF CONTRACTION AND CREATION |
| EP14708926.2A EP2958599B1 (en) | 2013-02-22 | 2014-02-21 | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
| PCT/FI2014/050131 WO2014128354A1 (en) | 2013-02-22 | 2014-02-21 | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20135172A FI126109B (fi) | 2013-02-22 | 2013-02-22 | Nanofibrillipolysakkaridi käytettäväksi kuroutumisen ja arpeutumisen hallitsemiseen ja estoon |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI20135172A FI20135172A (fi) | 2014-08-23 |
| FI126109B true FI126109B (fi) | 2016-06-30 |
Family
ID=50239668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20135172A FI126109B (fi) | 2013-02-22 | 2013-02-22 | Nanofibrillipolysakkaridi käytettäväksi kuroutumisen ja arpeutumisen hallitsemiseen ja estoon |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9833540B2 (fi) |
| EP (1) | EP2958599B1 (fi) |
| CA (1) | CA2897514C (fi) |
| DK (1) | DK2958599T3 (fi) |
| ES (1) | ES2614908T3 (fi) |
| FI (1) | FI126109B (fi) |
| WO (1) | WO2014128354A1 (fi) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI127526B (fi) * | 2012-11-03 | 2018-08-15 | Upm Kymmene Corp | Menetelmä nanofibrilliselluloosan valmistamiseksi |
| FI129421B (fi) | 2014-03-12 | 2022-02-15 | Maelkki Yrjoe | Nanoselluloosan ja sen esiasteiden valmistus ja käyttö |
| BR112016028230B1 (pt) * | 2014-05-30 | 2022-05-17 | Borregaard As | Celulose microfibrilada e dispersão semelhante a gel da celulose microfibrilada |
| FI126398B (fi) | 2014-12-18 | 2016-11-15 | Upm Kymmene Corp | Menetelmä kemikaalitestausta varten |
| FI125884B2 (fi) | 2014-12-22 | 2019-03-29 | Upm Kymmene Corp | Nanofibrilliselluloosan hydrogeelin käsittely korkeassa lämpötilassa |
| FI125882B (fi) | 2014-12-22 | 2016-03-31 | Upm Kymmene Corp | Nanofibrilliselluloosan hydrogeelin lämpökäsittely |
| FI126120B (fi) * | 2014-12-22 | 2016-06-30 | Upm Kymmene Corp | Prosessi hapetetun nanofibrilliselluloosan hydrogeelin tuottamiseksi |
| EP3268051A4 (en) * | 2015-03-13 | 2018-08-15 | Joslin Diabetes Center, Inc. | Methods to accelerate wound healing in diabetic subjects |
| FI127834B (fi) | 2015-06-04 | 2019-03-29 | Upm Kymmene Corp | Prosessi nanofibrilliselluloosan hydrogeelin tuottamiseksi |
| ES2706489T3 (es) * | 2015-12-31 | 2019-03-29 | Upm Kymmene Corp | Un producto médico de multi-capa que comprende celulosa nanofibrilar y un método de preparación del mismo |
| DK3228329T3 (da) * | 2016-04-06 | 2022-08-29 | Upm Kymmene Corp | Fremgangsmåde til fremkomst af et lægemiddel, omfattende nanofibrillar cellulose og et lægemiddel |
| EP3335740A1 (en) | 2016-12-15 | 2018-06-20 | UPM-Kymmene Corporation | Medical hydrogel |
| DE102017010930A1 (de) | 2017-11-25 | 2019-05-29 | Dr. 3 Entwicklungsgesellschaft mbH i. Gr. | Topische Zubereitungen |
| SI3533458T1 (sl) * | 2018-03-02 | 2023-09-29 | Upm-Kymmene Corporation | Medicinski izdelek, ki vsebuje bioaktivno molekulo, ki je imobilizirana na nanofibrilarno celulozo in postopek za njegovo pripravo |
| TWI693929B (zh) * | 2018-06-27 | 2020-05-21 | 南六企業股份有限公司 | 抗菌創傷敷料 |
| EP3987011A1 (en) * | 2019-06-24 | 2022-04-27 | UPM-Kymmene Corporation | Transplantable cell composition comprising eukaryotic cells in a nanofibrillar cellulose hydrogel, method for preparing thereof and use of nanofibrillar cellulose |
| KR102344588B1 (ko) * | 2019-06-25 | 2021-12-30 | 네이처코스텍 주식회사 | 변성 셀룰로오스를 포함하는 피부필러용 조성물 |
| EP3991761A4 (en) * | 2019-06-26 | 2023-01-11 | Nature Costech Co., Ltd. | DERMAL FILLER COMPOSITION WITH MODIFIED CELLULOSE |
| US20220305170A1 (en) | 2019-07-05 | 2022-09-29 | OJl HOLDINGS CORPORATION | Wound-covering material and production method therefor |
| EP3771470A1 (en) * | 2019-07-29 | 2021-02-03 | UPM-Kymmene Corporation | Medical hydrogel comprising nanofibrillar cellulose, tailored wound dressing, and methods for preparing thereof |
| KR102497989B1 (ko) * | 2019-09-02 | 2023-02-10 | 주식회사 에이엔폴리 | 지혈 드레싱제 |
| EP3791858A1 (en) * | 2019-09-13 | 2021-03-17 | UPM-Kymmene Corporation | Injectable pharmaceutical formulation |
| EP3791864A1 (en) | 2019-09-13 | 2021-03-17 | UPM-Kymmene Corporation | Method for preparing pharmaceutical composition and pharmaceutical composition |
| EP3816338A1 (en) * | 2019-10-31 | 2021-05-05 | UPM-Kymmene Corporation | Medical product and method for preparing thereof |
| KR102391943B1 (ko) * | 2019-11-26 | 2022-04-29 | 네이처코스텍 주식회사 | 변성 셀룰로오스와 히알루론산 함유 피부필러용 조성물 |
| US20240091399A1 (en) * | 2022-09-09 | 2024-03-21 | Upm-Kymmene Corporation | Medical grade nanofibrillar cellulose hydrogel, a method for treating a subject in need of treatment of body with implantable material and a method for manufacturing the medical grade nanofibrillar cellulose hydrogel |
| EP4335467A1 (en) * | 2022-09-09 | 2024-03-13 | UPM-Kymmene Corporation | A medical grade nanofibrillar cellulose hydrogel for use as implantable material |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3783073T2 (de) | 1986-04-22 | 1993-04-29 | Ajinomoto Kk | Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen. |
| US8951551B2 (en) | 2005-08-31 | 2015-02-10 | Board Of Regents, The University Of Texas System | Multiribbon nanocellulose as a matrix for wound healing |
| BRPI0601330A (pt) | 2006-03-31 | 2007-12-04 | Wellborn Participacoes Societa | composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais |
| WO2008010199A2 (en) * | 2006-07-18 | 2008-01-24 | Nanopeutics S.R.O. | A nanofibre product |
| US9180166B2 (en) * | 2010-03-12 | 2015-11-10 | New Jersey Institute Of Technology | Cartilage repair systems and applications utilizing a glycosaminoglycan mimic |
| ES2471367T3 (es) | 2010-07-30 | 2014-06-26 | Institut Quimic De Sarria | Implante bioactivo |
| FI123988B (fi) | 2010-10-27 | 2014-01-31 | Upm Kymmene Corp | Soluviljelymateriaali |
| WO2012106707A2 (en) * | 2011-02-04 | 2012-08-09 | Bc Genesis Llc | Biosynthetic functional cellulose (bc) fibers as surgical sutures and reinforcement of implants and growing tissue |
| FI126259B (fi) | 2011-02-11 | 2016-09-15 | Upm Kymmene Corp | Mikrofibrilloitu selluloosa käytettäväksi erityisesti atooppisen ihotulehduksen ja psoriasiksen hoidossa |
| US9211256B2 (en) | 2011-03-08 | 2015-12-15 | The Johns Hopkins University | Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof |
-
2013
- 2013-02-22 FI FI20135172A patent/FI126109B/fi active IP Right Grant
-
2014
- 2014-02-21 EP EP14708926.2A patent/EP2958599B1/en active Active
- 2014-02-21 ES ES14708926.2T patent/ES2614908T3/es active Active
- 2014-02-21 DK DK14708926.2T patent/DK2958599T3/en active
- 2014-02-21 US US14/767,857 patent/US9833540B2/en active Active
- 2014-02-21 WO PCT/FI2014/050131 patent/WO2014128354A1/en active Application Filing
- 2014-02-21 CA CA2897514A patent/CA2897514C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2614908T3 (es) | 2017-06-02 |
| EP2958599B1 (en) | 2016-11-16 |
| CA2897514C (en) | 2021-10-26 |
| CA2897514A1 (en) | 2014-08-28 |
| US20150367024A1 (en) | 2015-12-24 |
| DK2958599T3 (en) | 2017-02-20 |
| FI20135172A (fi) | 2014-08-23 |
| WO2014128354A1 (en) | 2014-08-28 |
| US9833540B2 (en) | 2017-12-05 |
| EP2958599A1 (en) | 2015-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2958599B1 (en) | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring | |
| Arif et al. | Polymer-based biomaterials for chronic wound management: Promises and challenges | |
| Sahana et al. | Biopolymers: Applications in wound healing and skin tissue engineering | |
| Graça et al. | Hyaluronic acid—Based wound dressings: A review | |
| Portela et al. | Bacterial cellulose: a versatile biopolymer for wound dressing applications | |
| Picheth et al. | Bacterial cellulose in biomedical applications: A review | |
| EP3335696B1 (en) | A method for drying cell-free tissue extract in a hydrogel comprising nanofibrillar cellulose and a dried hydrogel comprising nanofibrillar cellulose and cell-free tissue extract | |
| Muzzarelli | Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone | |
| Kaur et al. | Biomaterials-based regenerative strategies for skin tissue wound healing | |
| JP6576933B2 (ja) | パターニングされたメンブレン | |
| Moura et al. | Recent advances on the development of wound dressings for diabetic foot ulcer treatment—A review | |
| US8951551B2 (en) | Multiribbon nanocellulose as a matrix for wound healing | |
| Sikka et al. | The role of biopolymers and biodegradable polymeric dressings in managing chronic wounds | |
| Wang et al. | Shape-recoverable hyaluronic acid–waterborne polyurethane hybrid cryogel accelerates hemostasis and wound healing | |
| JP2021527736A (ja) | ナノフィブリルセルロース製品及びその製造方法 | |
| ter Horst et al. | Natural polymers: Biomaterials for skin scaffolds | |
| MX2014005738A (es) | Composiciones polimericas reticulables in-situ y metodos de las mismas. | |
| AU2006249270A8 (en) | Wound dressings comprising oxidized cellulose and human recombinant collagen | |
| US20210030919A1 (en) | Medical hydrogel comprising nanofibrillar cellulose, tailored wound dressing, and methods for preparing thereof | |
| JP2021020070A5 (fi) | ||
| Seifi et al. | A novel multifunctional chitosan-gelatin/carboxymethyl cellulose-alginate bilayer hydrogel containing human placenta extract for accelerating full-thickness wound healing | |
| CN111840634A (zh) | 一种葡萄籽提取物水凝胶的制备方法及应用 | |
| Ansari et al. | A review of the current state of natural biomaterials in wound healing applications | |
| Davenport et al. | Engineered biomaterials for chronic wound healing | |
| Bibire et al. | Biopolymers for Surgical Applications. Coatings 2022, 12, 211 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 126109 Country of ref document: FI Kind code of ref document: B |